Goss PE - Search Results

1

Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women.

Goss PE, Hadji P, Subar M, Abreu P, Thomsen T, Banke-Bochita J. Goss PE, et al. Breast Cancer Res. 2007;9(4):R52. doi: 10.1186/bcr1757. Breast Cancer Res. 2007. PMID: 17692126 Free PMC article. Clinical Trial.

2

The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model.

Goss PE, Qi S, Hu H, Cheung AM. Goss PE, et al. Breast Cancer Res Treat. 2007 Jul;103(3):293-302. doi: 10.1007/s10549-006-9381-y. Epub 2006 Oct 25. Breast Cancer Res Treat. 2007. PMID: 17063268

3

Letrozole in the extended adjuvant setting: MA.17.

Goss PE. Goss PE. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):45-53. doi: 10.1007/s10549-007-9698-1. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912635 Free PMC article. Clinical Trial.

4

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.

Buzdar AU, Coombes RC, Goss PE, Winer EP. Buzdar AU, et al. Among authors: goss pe. Cancer. 2008 Feb 1;112(3 Suppl):700-709. doi: 10.1002/cncr.23193. Cancer. 2008. PMID: 18072256 Free article.

5

Extended adjuvant endocrine therapy in breast cancer: current status and future directions.

Goss PE, Muss HB, Ingle JN, Whelan TJ, Wu M. Goss PE, et al. Clin Breast Cancer. 2008 Oct;8(5):411-7. doi: 10.3816/CBC.2008.n.049. Clin Breast Cancer. 2008. PMID: 18952554 Review.

6

National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: evaluation of exemestane to prevent breast cancer in postmenopausal women.

Goss PE, Richardson H, Chlebowski R, Johnston D, Sarto GE, Maunsell E, Ingle JN, Alés-Martinez JE. Goss PE, et al. Clin Breast Cancer. 2007 Dec;7(11):895-900. doi: 10.3816/CBC.2007.n.057. Clin Breast Cancer. 2007. PMID: 18269782 Clinical Trial. No abstract available.

7

Extending the benefits of adjuvant therapy in early HR+ breast cancer.

Goss PE. Goss PE. Breast Cancer Res Treat. 2008 Dec;112 Suppl 1:45-52. doi: 10.1007/s10549-008-0129-8. Epub 2008 Sep 11. Breast Cancer Res Treat. 2008. PMID: 18785006

8

Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27.

Chapman JA, Shepherd LE, Ingle JN, Muss HB, Pritchard KI, Gelmon KA, Whelan TJ, Elliott C, Goss PE. Chapman JA, et al. Among authors: goss pe. Breast Cancer Res Treat. 2016 Apr;156(2):343-9. doi: 10.1007/s10549-016-3761-8. Epub 2016 Mar 23. Breast Cancer Res Treat. 2016. PMID: 27006189 Free PMC article. Clinical Trial.

9

Exemestane for breast-cancer prevention in postmenopausal women.

Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW, Winquist E, Sarto GE, Garber JE, Fabian CJ, Pujol P, Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H; NCIC CTG MAP.3 Study Investigators. Goss PE, et al. N Engl J Med. 2011 Jun 23;364(25):2381-91. doi: 10.1056/NEJMoa1103507. Epub 2011 Jun 4. N Engl J Med. 2011. PMID: 21639806 Free article. Clinical Trial.

10

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.

Goss PE, Ingle JN, Pritchard KI, Ellis MJ, Sledge GW, Budd GT, Rabaglio M, Ansari RH, Johnson DB, Tozer R, D'Souza DP, Chalchal H, Spadafora S, Stearns V, Perez EA, Liedke PE, Lang I, Elliott C, Gelmon KA, Chapman JA, Shepherd LE. Goss PE, et al. J Clin Oncol. 2013 Apr 10;31(11):1398-404. doi: 10.1200/JCO.2012.44.7805. Epub 2013 Jan 28. J Clin Oncol. 2013. PMID: 23358971 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page